Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?

Stefan Leucht; Maximilian Huhn; John M. Davis

doi:10.1007/s00406-021-01335-y

Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?

Stefan Leucht, Maximilian Huhn, John M. Davis

Department of Psychiatry and Psychotherapy

Research output: Contribution to journal › Editorial

6 Scopus citations

Original language	English
Pages (from-to)	1411-1413
Number of pages	3
Journal	European Archives of Psychiatry and Clinical Neuroscience
Volume	271
Issue number	8
DOIs	https://doi.org/10.1007/s00406-021-01335-y
State	Published - Dec 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00406-021-01335-y

Cite this

@article{b856a2b0982c4ff796acbcaacbd48308,

title = "Should {\textquoteleft}typical{\textquoteright}, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?",

author = "Stefan Leucht and Maximilian Huhn and Davis, {John M.}",

year = "2021",

month = dec,

doi = "10.1007/s00406-021-01335-y",

language = "English",

volume = "271",

pages = "1411--1413",

journal = "European Archives of Psychiatry and Clinical Neuroscience",

issn = "0940-1334",